Information  X 
Enter a valid email address

BIOTECH GWTH (BIOG)

Related News

09-Nov-2018 03:03 PM

Biotech Growth Trust returns jump 20% in first half

Biotech Growth Trust said it boosted its net asset value per share by 20% in the first half, though it still underperformed its benchmark. This Nasdaq Biotechnology Index, measured in sterling terms, rose 23% over the same period. 'The company&apos
06-Dec-2017 01:45 PM

Biotech GT notes announcement by portfolio manager

Biotech Growth Trust said it has noted that the General Partners of OrbiMed Capital, which acts as portfolio manager to the Company, released a statement late on 5 December concerning Founding Partner Samuel Isaly, who is the subject of a press article co
13-Jul-2017 08:41 AM

Biotech Growth Trust director retires

Biotech Growth Trust director Peter Keen has retired with immediate effect. At 8:41am: (LON:BIOG) Biotech Gwth share price was -7.5p at 789.5p Story provided by StockMarketWire.com...
25-May-2017 01:54 PM

Biotech GT NAV rises 27.5%

The Biotech Growth Trust has reported that its net asset value per share rose by 27.5%, during the year ended 31 March 2017, compared to the Company's benchmark, the NASDAQ Biotechnology Index (sterling adjusted), which rose by 29.2%. The share pric
07-Nov-2016 03:17 PM

Biotech Growth Trust schedules interims

The Biotech Growth Trust will announce its results for the six months to the end of September on 16 November. At 3:17pm: (LON:BIOG) Biotech Gwth share price was +13.75p at 641.5p Story provided by StockMarketWire.com...
13-Jul-2016 09:39 AM

Biotech Growth Trust resolutions passed at AGM

The Biotech Growth Trust has confirmed that all resolutions proposed at its annual general meeting yesterday were passed. At 9:39am: (LON:BIOG) Biotech Gwth share price was -2.5p at 657.5p Story provided by StockMarketWire.com...
13-Jul-2016 08:34 AM

Biotech chairman steps down

The Biotech Growth Trust non-executive chairman Lord Waldegrave of North Hill has retired from the board and been succeeded by Andrew Joy. Professor Dame Kay Davies has taken over from Joy as the company's senior independent director and a chairman
08-Jul-2015 03:43 PM

Steve Bates joins Biotech Growth Trust board

The Biotech Growth Trust has appointed Steve Bates as an independent non-executive director. The company says Bates has a wealth of experience as an investment manager and holds several non-executive investment trust directorships. At 3:43pm: (LON:BIO
08-Jul-2015 01:55 PM

Biotech Growth Trust resolutions passed at AGM

The Biotech Growth Trust has confirmed that all resolutions proposed at its annual general meeting today were passed. The company also announced that Paul Gaunt has retired as a director with immediate effect. At 1:55pm: (LON:BIOG) Biotech Gwth share p
06-Mar-2015 01:46 PM

Biotech Growth seeks approval to change investment policy

The Biotech Growth Trust is seeking shareholder approval for a change to its investment policy. The directors, as advised by the company's AIFM and portfolio manager, are proposing that the company's borrowing limit be increased from 15% to 20
11-Nov-2014 07:27 AM

Biotech Growth Trust beats benchmark

The Biotech Growth Trust beat its benchmark in the six months to the end of September. The company's net asset value rose by 20.3% in the period compared with a 19.1% increase in the NASDAQ Biotechnology Index (sterling adjusted). Story provide
10-Jul-2014 02:29 PM

Biotech Growth Trust resolutions passed at AGM

The Biotech Growth Trust has confirmed that all resolutions proposed at the annual general meeting today were passed. At 2:29pm: (LON:BIOG) Biotech Gwth share price was -6.75p at 477.25p Story provided by StockMarketWire.com...
10-Jul-2014 02:20 PM

Biotech Growth Trust names new SID

Biotech Growth Trust has announced that Andrew Joy has become the senior independent director and chairman of the remuneration committee with immediate effect following the retirement from the board of Dr John Gordon. At 2:20pm: (LON:BIOG) Biotech Gwth
22-May-2014 04:27 PM

Biotech Growth Trust NAV up 34.2%

The Biotech Growth Trust's net asset value per share increased by 34.2% in the year to the end of March. This was broadly in line with its benchmark, the NASDAQ Biotechnology Index, sterling adjusted, which rose by 34.7%. The company said: "
09-Aug-2013 02:03 PM

Biotech Growth Trust lags benchmark

The Biotech Growth Trust's net asset value rose by 2.7% in the three months to the end of June compared to an 8.7% increase in its benchmark, the NASDAQ Biotechnology Index measured in sterling terms. The company's share price rose by 4.8% and
23-Nov-2012 02:54 PM

Biotech Growth Trust beats index

Biotech Growth Trust's net asset value per share rose by 18.4% in the six months to the end of September. This compares with a 14.9% rise in the NASDAQ Biotechnology Index on a sterling adjusted basis. The company's share price rose by 25.4% i
17-Apr-2012 09:36 AM

BioGaia signs Taiwan distribution deal with Unilab

BioGaia has signed an exclusive distribution agreement for its probiotic drops and tablets in Taiwan with Unilab Group. The products will be sold under the BioGaia brand and launch is planned for this year. Unilab Group, based in the Philippines, is a
15-Feb-2012 09:04 AM

BioGaia extends collaboration with Nestl�©

BioGaia and Nestl�© are extending their collaboration on infant nutrition products which began in 2008. BioGaia says these agreements are of significant strategic value for the company since they not only involve an extended close collaboration with
10-Feb-2012 08:49 AM

BioGaia pre-tax profits up 56%

Pre-tax profits at BioGaia jumped by 56% to SEK108.9m in 2011 after net sales rose 33% to SEK315.0m. Excluding foreign exchange effects, net sales grew by 40%. Operating profit rose by 83% to SEK103.2m. Excluding foreign exchange effects, operating pr
07-Feb-2012 03:49 PM

Biotech Growth Trust beats benchmark

The Biotech Growth Trust's net asset value per share rose by 14.2% in the three months to the end of December. This compares with a 12.9% rise in its benchmark, the NASDAQ Biotechnology Index, measured in sterling terms. The xompany's share p
30-Nov-2011 02:39 PM

Biotech Growth Trust beats benchmark

Biotech Growth Trust's net asset value per share fell by 1.5% in the six months to the end of September. This compares with a 4.4% fall in the NASDAQ Biotechnology Index on a sterling adjusted basis. At 2:39pm: (LON:BIOG) share price was +2p at
23-Nov-2011 03:18 PM

Biotech Growth Trust beats benchmark

Biotech Growth Trust's net asset value per share fell by 1.5% in the six months to the end of September. This compares with a 4.4% fall in the NASDAQ Biotechnology Index, on a sterling adjusted basis. The company's share price rose by 4.5% dur
02-Aug-2011 10:01 AM

Biotech Growth Trust NAV up

Biotech Growth Trust's net asset value per share rose to 205.81p at the end of June - up from 186.00p at the end of March. The share price increased to 191.25p from 166.00p. Net assets increased to £132.0m from £120.8m. At 10:01am: (LON:BIOG) sh
31-May-2011 03:35 PM

Biotech Growth Trust lags benchmark

Biotech Growth Trust's net asset value per share rose by 1.9% in the year to the end of March. This compares with a 4.8% increase in its benchmark, the NASDAQ Biotechnology Index on a sterling adjusted basis. The company's share price fell by
15-Feb-2011 02:21 PM

Biotech Growth Trust underperforms

In the three month period ended 31 December 2010 the net asset value per share of Biotech Growth Trust rose by 4.9% compared to a rise of 9.3% in the company's benchmark, the NASDAQ Biotechnology Index, measured in sterling terms. The underperforman
 
Headlines
Top categories
Company finder
Forthcoming announcements

a d v e r t i s e m e n t